Zenpep Approval History
- FDA approved: Yes (First approved August 27th, 2009)
- Brand name: Zenpep
- Generic name: pancrelipase
- Dosage form: Capsules
- Previous name: Zentase
- Company: Allergan, Inc.
- Treatment for: Pancreatic Exocrine Dysfunction
Zenpep (pancrelipase) is a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, or other conditions.
Development History and FDA Approval Process for Zenpep
|Aug 28, 2009||Eurand Granted FDA Approval for Zenpep|
|Jun 19, 2008||Eurand Receives Approvable Letter From FDA for EUR-1008 (Zentase)|
|Feb 21, 2008||Eurand Granted Priority Review for Zentase NDA|
|Dec 20, 2007||Eurand Completes New Drug Application for Zentase|
|Jun 12, 2007||Eurand Files NDA for Zentase for Exocrine Pancreatic Insufficiency|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.